Cosmos Health (Cosmos Health) Change In Receivables : $-8.06 Mil (TTM As of Sep. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Cosmos Health Change In Receivables?

Cosmos Health's change in receivables for the quarter that ended in Sep. 2023 was $-3.13 Mil. It means Cosmos Health's Accounts Receivable increased by $3.13 Mil from Jun. 2023 to Sep. 2023 .

Cosmos Health's change in receivables for the fiscal year that ended in Dec. 2022 was $-7.46 Mil. It means Cosmos Health's Accounts Receivable increased by $7.46 Mil from Dec. 2021 to Dec. 2022 .

Cosmos Health's Accounts Receivable for the quarter that ended in Sep. 2023 was $25.59 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Cosmos Health's Days Sales Outstanding for the three months ended in Sep. 2023 was 182.09.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cosmos Health's liquidation value for the three months ended in Sep. 2023 was $-2.41 Mil.

Cosmos Health Change In Receivables Historical Data

The historical data trend for Cosmos Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmos Health Change In Receivables Chart

Cosmos Health Annual Data

Trend

Jul13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

0.47

-4.33

-15.81

-8.46

-7.46

Cosmos Health Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Receivables	Get a 7-Day Free Trial															-0.66	-5.68	0.52	0.24	-3.13

Cosmos Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.06 Mil.

Cosmos Health (NAS:COSM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cosmos Health's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	25.591	/	12.824	*	91
=	182.09

2. In Ben Graham's calculation of liquidation value, Cosmos Health's accounts receivable are only considered to be worth 75% of book value:

Cosmos Health's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2.378	-	26.957	+	0.75 * 25.591	+	0.5 * 5.96
=	-2.41

Cosmos Health Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cosmos Health's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmos Health (Cosmos Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (NAS:COSM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

V67A:Germany

Address

141 West Jackson Boulevard, Suite 4236, Chicago, IL, USA, 60604

Website

https://www.cosmoshold.com

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.

Executives

Grigorios Siokas	10 percent owner	5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001
Suhel Bhutawala	director	141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Nikolaos Bardakis	officer: Chief Operating Officer	141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Manfred Ziegler	director	141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Anastasios Aslidis	director	11 CANTERBURY LANE, WATCHUNG NJ 07069
Pavlos Ignatiades	officer: Chief Operating Officer	KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236
Georgios Terzis	officer: Chief Financial Officer	2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121
Peter Goldstein	director	151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324
John James Hoidas	director	9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453
Dimitrios Goulielmos	director, 10 percent owner, officer: CEO	141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604
Panagiotis Tolis	director, officer: Secretary	PERICLEOUS 50 STREET, ATHENS J3 15232
Panagiotis Drakopoulos	director, 10 percent owner, officer: CEO	200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606
Vasileios Mavrogiannis	director, 10 percent owner, officer: CFO	TERTSETI 23 STREET, KESARIANI J3 16122